EFM
E Fund Management’s Amicus Therapeutics FOLD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $265K | Buy |
46,326
+22,610
| +95% | +$130K | 0.01% | 326 |
|
|
2025
Q1 | $194K | Buy |
23,716
+21
| +0.1% | +$171 | 0.01% | 365 |
|
|
2024
Q4 | $223K | Sell |
23,695
-2,472
| -9% | -$23.3K | 0.01% | 349 |
|
|
2024
Q3 | $279K | Sell |
26,167
-1,567
| -6% | -$16.7K | 0.01% | 271 |
|
|
2024
Q2 | $275K | Sell |
27,734
-7,498
| -21% | -$74.4K | 0.02% | 244 |
|
|
2024
Q1 | $415K | Sell |
35,232
-7,316
| -17% | -$86.2K | 0.03% | 206 |
|
|
2023
Q4 | $604K | Buy |
42,548
+6,171
| +17% | +$87.6K | 0.04% | 124 |
|
|
2023
Q3 | $442K | Buy |
36,377
+1,510
| +4% | +$18.3K | 0.03% | 146 |
|
|
2023
Q2 | $438K | Buy |
34,867
+1,109
| +3% | +$13.9K | 0.03% | 141 |
|
|
2023
Q1 | $374K | Sell |
33,758
-2,403
| -7% | -$26.6K | 0.03% | 189 |
|
|
2022
Q4 | $442K | Sell |
36,161
-5,551
| -13% | -$67.9K | 0.04% | 158 |
|
|
2022
Q3 | $435K | Sell |
41,712
-10,727
| -20% | -$112K | 0.04% | 162 |
|
|
2022
Q2 | $563K | Buy |
52,439
+23,564
| +82% | +$253K | 0.05% | 125 |
|
|
2022
Q1 | $273K | Buy |
28,875
+12,006
| +71% | +$114K | 0.01% | 228 |
|
|
2021
Q4 | $195K | Buy |
16,869
+1,098
| +7% | +$12.7K | 0.01% | 267 |
|
|
2021
Q3 | $151K | Buy |
+15,771
| New | +$151K | 0.01% | 250 |
|
|
2021
Q1 | $127K | Buy |
+12,862
| New | +$127K | 0.01% | 230 |
|